Trials / Terminated
TerminatedNCT03373422
A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best
A Randomized, Placebo-controlled, Double-blind, Parallel-group, Multi-center, Exploratory Dose-response Study to Assess the Efficacy and Safety of Different Oral Doses of BAY1128688 in Women With Symptomatic Endometriosis Over a 12-week Treatment Period
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purpose of the study is to test whether study drug BAY1128688 brings relief for pain to women with endometriosis and if so to get a first impression which dose(s) work best.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BAY1128688 | Various dosing OD (once daily) and BID (twice daily) |
| DRUG | Placebo | Matching placebo tablets |
Timeline
- Start date
- 2017-11-30
- Primary completion
- 2018-07-23
- Completion
- 2018-10-22
- First posted
- 2017-12-14
- Last updated
- 2019-10-03
Locations
68 sites across 13 countries: Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT03373422. Inclusion in this directory is not an endorsement.